EXACT Sciences

- NASDAQ:EXAS
Last Updated 2020-05-30
  • About

    Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting
  • Domains

  • Locations

    • Madison WI
  • Total Funding (USD)

    8.2 million
  • Acquisitions (4)

    • Genomic Health (2019)
    • Biomatrica (2018)
    • Armune BioScience (2018)
    • Sampleminded (2017)
  • Security

    Type: ORD
    CUSIP: 30063P105
    ISIN: US30063P1057
  • Related Bookmarks

Request a demo to view additional historical data, and much more.